Inventor
FURCHT LEO T
US38 patents
⚠️ This page may combine multiple inventors who share the name “FURCHT LEO T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MINNESOTA
24 patentsUS6054277AApr 25, 2000
Integrated microchip genetic testing system
UNIV MINNESOTA380 citations98
US6303288B1Oct 16, 2001
Integrated microchip genetic testing system
UNIV MINNESOTA88 citations97
US5294551AMar 15, 1994
Cell culture substrate coated with polypeptides having fibronectin activity
UNIV MINNESOTA35 citations92
US5019646AMay 28, 1991
Polypeptides with fibronectin activity
UNIV MINNESOTA41 citations92
US4839464AJun 13, 1989
Polypeptides with fibronectin activity
UNIV MINNESOTA24 citations92
US5266328ANov 30, 1993
Laminin a chain polypeptides from the carboxy terminal globular domain
UNIV MINNESOTA21 citations91
US6013628AJan 11, 2000
Method for treating conditions of the eye using polypeptides
UNIV MINNESOTA61 citations88
US5711959AJan 27, 1998
Biocompatible materials
UNIV MINNESOTA43 citations88
US9789136B2Oct 17, 2017
Multipotent adult stem cells and methods for isolation
UNIV MINNESOTA5 citations84
US5276136AJan 4, 1994
Laminin A chain polypeptides from the amino terminal globular domain
UNIV MINNESOTA15 citations80
US5081031AJan 14, 1992
Synthetic polypeptide with type iv collagen activity
UNIV MINNESOTA17 citations80
US4870160ASep 26, 1989
Polypeptides with laminin activity
UNIV MINNESOTA23 citations79
US4797473AJan 10, 1989
Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
UNIV MINNESOTA21 citations78
US5731409AMar 24, 1998
Polypeptides with type I collagen activity
UNIV MINNESOTA10 citations73
US5171271ADec 15, 1992
Polypeptides with fibronectin activity
UNIV MINNESOTA9 citations73
US5147797ASep 15, 1992
Polypeptides with fibronectin activity
UNIV MINNESOTA8 citations73
US5116368AMay 26, 1992
Polypeptides with fibronectin activity
UNIV MINNESOTA13 citations73
US5703205ADec 30, 1997
Laminin a chain polypeptides from the amino terminal golbular domain
UNIV MINNESOTA5 citations72
US5591719AJan 7, 1997
Method for treating acute and chronic inflammatory disorders using polypeptides with fibronectin activity
UNIV MINNESOTA15 citations72
US5242826ASep 7, 1993
Polypeptides for adhering cells to a substrate
UNIV MINNESOTA7 citations72
US5059425AOct 22, 1991
Bandage comprising a fibrous surface coated with polypeptides with type IV collagen activity
UNIV MINNESOTA9 citations72
US5007925AApr 16, 1991
Prosthetic devices coated with polypeptides with type IV collagen activity
UNIV MINNESOTA9 citations72
US12171785B2Dec 24, 2024
Pluripotent cells derived from bone marrow and methods for isolation
UNIV MINNESOTA0 citations62
US6849712B1Feb 1, 2005
Peptides with β1 integrin subunit dependent cell adhesion modulating activity
UNIV MINNESOTA5 citations57
FURCHT LEO T
6 patentsUS10006004B2Jun 26, 2018
Multipotent adult stem cells and methods for isolation
FURCHT LEO T6 citations83
US9974810B2May 22, 2018
Multipotent adult stem cells and methods for isolation
FURCHT LEO T3 citations83
US9974809B2May 22, 2018
Multipotent adult stem cells and methods for isolation
FURCHT LEO T3 citations83
US9974811B2May 22, 2018
Multipotent adult stem cells and methods for isolation
FURCHT LEO T3 citations83
US10638734B2May 5, 2020
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
FURCHT LEO T2 citations72
US10226485B2Mar 12, 2019
Multipotent adult stem cells and methods for isolation
FURCHT LEO T2 citations72
ABT HOLDING CO
2 patentsVERFAILLIE CATHERINE M
2 patentsUS8075881B2Dec 13, 2011
Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
VERFAILLIE CATHERINE M49 citations97
US9526747B2Dec 27, 2016
Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
VERFAILLIE CATHERINE M6 citations83